MIRA INFORM REPORT

 

 

Report Date :

21.05.2014

 

IDENTIFICATION DETAILS

 

Name :

VENTURE LIMITED

 

 

Registered Office :

One Prospect West, Chippenham, Wiltshire, Sn14 6fh

 

 

Country :

United Kingdom

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

03.02.1983

 

 

Com. Reg. No.:

01696917

 

 

Legal Form :

Private Limited With Share Capital

 

 

Line of Business :

Other Human Health Activities Research, Development and Commercialisation of Pharmaceutical Products And Technologies.

 

 

No. of Employees

177

 

RATING & COMMENTS

 

MIRA’s Rating :

Ca

 

RATING

STATUS

PROPOSED CREDIT LINE

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

Limited with full security

 

Status :

Moderate

Payment Behaviour :

Slow

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31, 2014

 

Country Name

Previous Rating

(31.12.2013)

Current Rating

(31.03.2014)

United Kingdom

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately  High Risk

C1

High Risk

 

C2

Very High Risk

 

D

 


 

UNITED KINGDOM - ECONOMIC OVERVIEW

 

The UK, a leading trading power and financial center, is the third largest economy in Europe after Germany and France. Over the past two decades, the government has greatly reduced public ownership. Agriculture is intensive, highly mechanized, and efficient by European standards, producing about 60% of food needs with less than 2% of the labor force. The UK has large coal, natural gas, and oil resources, but its oil and natural gas reserves are declining and the UK became a net importer of energy in 2005. Services, particularly banking, insurance, and business services, are key drivers of British GDP growth. Manufacturing, meanwhile, has declined in importance but still accounts for about 10% of economic output. After emerging from recession in 1992, Britain's economy enjoyed the longest period of expansion on record during which time growth outpaced most of Western Europe. In 2008, however, the global financial crisis hit the economy particularly hard, due to the importance of its financial sector. Falling home prices, high consumer debt, and the global economic slowdown compounded Britain's economic problems, pushing the economy into recession in the latter half of 2008 and prompting the then BROWN (Labour) government to implement a number of measures to stimulate the economy and stabilize the financial markets; these included nationalizing parts of the banking system, temporarily cutting taxes, suspending public sector borrowing rules, and moving forward public spending on capital projects. Facing burgeoning public deficits and debt levels, in 2010 the CAMERON-led coalition government (between Conservatives and Liberal Democrats) initiated a five-year austerity program, which aimed to lower London's budget deficit from about 11% of GDP in 2010 to nearly 1% by 2015. In November 2011, Chancellor of the Exchequer George OSBORNE announced additional austerity measures through 2017 largely due to the euro-zone debt crisis. The CAMERON government raised the value added tax from 17.5% to 20% in 2011. It has pledged to reduce the corporation tax rate to 21% by 2014. The Bank of England (BoE) implemented an asset purchase program of £375 billion (approximately $605 billion) as of December 2013. During times of economic crisis, the BoE coordinates interest rate moves with the European Central Bank, but Britain remains outside the European Economic and Monetary Union (EMU). In 2012, weak consumer spending and subdued business investment weighed on the economy, however, in 2013 GDP grew 1.4%, accelerating unexpectedly in the second half of the year because of greater consumer spending and a recovering housing market. The budget deficit is falling but remains high at nearly 7% and public debt has continued to increase

Source : CIA

 

 

 


REGISTERED NAME & COMPANY SUMMARY

 

Company Name:

VENTURE LIMITED

Company No.

01696917

Registered Address

ONE PROSPECT WEST

CHIPPENHAM

WILTSHIRE

SN14 6FH

Trading Address

University Of Bath

Claverton Down

Castle Cary

Somerset

BA7 7AY

Website Address

http://www.ventura.com

 

Telephone Number

01249667700

Fax Number

 

TPS

No

FPS

No

Incorporate Date

03/02/1983

 

 

Previous Name

COORDINATED DRUG DEVELOPMENT LIMITED

Type

Private limited with Share Capital

 

Disqualified

 

Disqualified End Date

 

Disqualification Exception

No

 

 

 

FTSE INDEX

-

Date of Change

13/07/2004

Filing Date of Accounts

21/11/2013

Currency

GBP

Share Capital

£4,200

SIC07

86900

 

 

SIC07 Description

 

 

 

Principal Activity

OTHER HUMAN HEALTH ACTIVITIES

Research, development and commercialisation of pharmaceutical products and technologies.

 

 

DIRECTORS/MANAGEMENT

 

Current Directors

Name

Christopher Paul Blackwell

Date of Birth

10/12/1961

Officers Title

Dr

Nationality

British

Present Appointments

18

Function

Director

Appointment Date

09/06/2004

 

 

Address

One Prospect West, Chippenham, Wiltshire, SN14 6FH

Other Actions

View Director Report

View Consumer Report

 

Disqualified

 

Disqualified End Date

 

Disqualification Exception

No

 

 

 

Name

Trevor Michael Phillips

Date of Birth

01/05/1961

Officers Title

Dr

Nationality

British

Present Appointments

3

Function

Director

Appointment Date

01/09/2012

 

 

Address

One Prospect West, Chippenham, Wiltshire, SN14 6FH

Other Actions

View Director Report

View Consumer Report

 

Disqualified

 

Disqualified End Date

 

Disqualification Exception

No

 

 

 

Name

Paul Oliver

Date of Birth

25/03/1978

Officers Title

Mr

Nationality

British

Present Appointments

18

Function

Director

Appointment Date

01/07/2013

 

 

Address

One Prospect West, Chippenham, Wiltshire, SN14 6FH

Other Actions

View Director Report

View Consumer Report

 

 

 

NEGATIVE INFORMATION

 

CCJ

Total Number of Exact CCJs -

0

Total Value of Exact CCJs -

Total Number of Possible CCJs -

0

Total Value of Possible CCJs -

Total Number of Satisfied CCJs -

0

Total Value of Satisfied CCJs -

Total Number of Writs -

-

 

 

Exact CCJ Details

No CCJs found

Possible CCJs Details

There are no possible CCJ details

Writ Details

No writs found

 

 

SHARE & SHARE CAPITAL INFORMATION

 

Top 20 Shareholders

Name

Currency

Share Count

Share Type

Nominal Value

% of Total Share Count

VECTURA GROUP INVESTMENTS LTD

GBP

4,200

ORDINARY

1

100

 

 

PAYMENT INFORMATION

 

Payment Trend

Stable

 

Within terms

Within terms 91+ Days

 

 

GROUP STRUCTURE & AFFILIATED COMPANIES

 

Statistics

Group

17 companies

Linkages

0 companies

Countries

In 0 countries

Summary

Holding Company

VECTURA GROUP INVESTMENTS LIMITED

Ownership Status

Wholly Owned

Ultimate Holding Company

VECTURA GROUP PLC

 

 

FINANCIAL INFORMATION

 

Profit & Loss

 

Date Of Accounts

31/03/13

(%)

31/03/12

(%)

31/03/11

(%)

31/03/10

(%)

31/03/09

 

Weeks

52

(%)

52

(%)

52

(%)

52

(%)

52

 

Currency

GBP

(%)

GBP

(%)

GBP

(%)

GBP

(%)

GBP

 

Consolidated A/cs

N

(%)

N

(%)

N

(%)

N

(%)

N

Turnover

£16,448,000

29.9%

£12,666,000

-26.6%

£17,249,000

24.1%

£13,900,000

202.2%

£4,600,000

Export

£12,068,000

64.7%

£7,329,000

-

-

-

-

-

-

Cost of Sales

£435,000

-59.3%

£1,068,000

-18.8%

£1,316,000

-6%

£1,400,000

-17.6%

£1,700,000

Gross Profit

£16,013,000

38.1%

£11,598,000

-27.2%

£15,933,000

27.5%

£12,500,000

331%

£2,900,000

Wages & Salaries

£9,951,000

9.3%

£9,105,000

-3.5%

£9,432,000

19.4%

£7,900,000

5.3%

£7,500,000

Directors Emoluments

£1,523,000

31.4%

£1,159,000

1.4%

£1,143,000

3.9%

£1,100,000

-

£1,100,000

Operating Profit

-£12,372,000

23.3%

-£16,125,000

-8.6%

-£14,849,000

-35%

-£11,000,000

39.2%

-£18,100,000

Depreciation

£930,000

-14.4%

£1,087,000

-0.5%

£1,093,000

21.4%

£900,000

-

£900,000

Audit Fees

£35,000

-

£35,000

-

£35,000

-

-

-100%

£40,000

Interest Payments

-

-

-

-

-

-

-

-

-

Pre Tax Profit

-£11,031,000

27.9%

-£15,308,000

-3.1%

-£14,848,000

-63.2%

-£9,100,000

34.5%

-£13,900,000

Taxation

£3,395,000

-26.9%

£4,646,000

81.3%

£2,562,000

-41.8%

£4,400,000

83.3%

£2,400,000

Profit After Tax

-£7,636,000

28.4%

-£10,662,000

13.2%

-£12,286,000

-161.4%

-£4,700,000

59.1%

-£11,500,000

Dividends Payable

-

-

-

-

-

-

-

-

-

Retained Profit

-£7,636,000

28.4%

-£10,662,000

13.2%

-£12,286,000

-161.4%

-£4,700,000

59.1%

-£11,500,000

 

 

Balance Sheet

 

 

Date Of Accounts

31/03/13

(%)

31/03/12

(%)

31/03/11

(%)

31/03/10

(%)

31/03/09

Tangible Assets

£9,321,000

48.3%

£6,286,000

104.8%

£3,070,000

9.6%

£2,800,000

-6.7%

£3,000,000

Intangible Assets

0

-

0

-

0

-

0

-

0

Total Fixed Assets

£9,321,000

48.3%

£6,286,000

104.8%

£3,070,000

9.6%

£2,800,000

-6.7%

£3,000,000

Stock

0

-

0

-

0

-

0

-

0

Trade Debtors

£122,000

-84.1%

£768,000

-60.7%

£1,952,000

14.8%

£1,700,000

70%

£1,000,000

Cash

£70,091,000

-7.2%

£75,528,000

1.5%

£74,408,000

16.1%

£64,100,000

-12.6%

£73,300,000

Other Debtors

£34,889,000

7.4%

£32,486,000

20.3%

£27,009,000

-6.2%

£28,800,000

380%

£6,000,000

Miscellaneous Current Assets

0

-

0

-

0

-

0

-

0

Total Current Assets

£105,102,000

-3.4%

£108,782,000

5.2%

£103,369,000

9.3%

£94,600,000

17.8%

£80,300,000

Trade Creditors

£3,149,000

53.7%

£2,049,000

22.7%

£1,670,000

-35.8%

£2,600,000

-

£2,600,000

Bank Loans & Overdrafts

0

-

0

-

0

-

0

-

0

Other Short Term Finance

£144,481,000

10.5%

£130,782,000

12.6%

£116,178,000

15.8%

£100,300,000

17.2%

£85,600,000

Miscellaneous Current Liabilities

£12,039,000

-39.2%

£19,814,000

17.9%

£16,807,000

60.1%

£10,500,000

64.1%

£6,400,000

Total Current Liabilities

£159,669,000

4.6%

£152,645,000

13.4%

£134,655,000

18.7%

£113,400,000

19.9%

£94,600,000

Bank Loans & Overdrafts and LTL

£1,268,000

-2.5%

£1,301,000

-

0

-

0

-

0

Other Long Term Finance

0

-

0

-

0

-

0

-

0

Total Long Term Liabilities

£1,268,000

-2.5%

£1,301,000

-

0

-

0

-

0

Capital & Reserves

 

Date Of Accounts

31/03/13

(%)

31/03/12

(%)

31/03/11

(%)

31/03/10

(%)

31/03/09

Called Up Share Capital

£4,000

-

£4,000

-

£4,000

-

-

-

-

P & L Account Reserve

-£46,519,000

-19.6%

-£38,883,000

-37.8%

-£28,221,000

-76.4%

-£16,000,000

-41.6%

-£11,300,000

Revaluation Reserve

-

-

-

-

-

-

-

-

-

Sundry Reserves

£1,000

-

£1,000

-

£1,000

-

-

-

-

Shareholder Funds

-£46,514,000

-19.6%

-£38,878,000

-37.8%

-£28,216,000

-76.4%

-£16,000,000

-41.6%

-£11,300,000

Other Financial Items

 

Date Of Accounts

31/03/13

(%)

31/03/12

(%)

31/03/11

(%)

31/03/10

(%)

31/03/09

Net Worth

-£46,514,000

-19.6%

-£38,878,000

-37.8%

-£28,216,000

-76.4%

-£16,000,000

-41.6%

-£11,300,000

Working Capital

-£54,567,000

-24.4%

-£43,863,000

-40.2%

-£31,286,000

-66.4%

-£18,800,000

-31.5%

-£14,300,000

Total Assets

£114,423,000

-0.6%

£115,068,000

8.1%

£106,439,000

9.3%

£97,400,000

16.9%

£83,300,000

Total Liabilities

£160,937,000

4.5%

£153,946,000

14.3%

£134,655,000

18.7%

£113,400,000

19.9%

£94,600,000

Net Assets

-£46,514,000

-19.6%

-£38,878,000

-37.8%

-£28,216,000

-76.4%

-£16,000,000

-41.6%

-£11,300,000

Cash Flow

 

Date Of Accounts

31/03/13

(%)

31/03/12

(%)

31/03/11

(%)

31/03/10

(%)

31/03/09

Net Cashflow from Operations

-£1,970,000

-144.4%

£4,439,000

-59.6%

£10,975,000

220.6%

-£9,100,000

-112.7%

£71,400,000

Net Cashflow before Financing

-£5,437,000

-585.4%

£1,120,000

-89.1%

£10,308,000

212%

-£9,200,000

-112.6%

£73,300,000

Net Cashflow from Financing

-

-

-

-

-

-

-

-

-

Increase in Cash

-£5,437,000

-585.4%

£1,120,000

-89.1%

£10,308,000

212%

-£9,200,000

-112.6%

£73,300,000

Miscellaneous

 

Date Of Accounts

31/03/13

(%)

31/03/12

(%)

31/03/11

(%)

31/03/10

(%)

31/03/09

 

Contingent Liability

NO

-

NO

-

NO

-

NO

-

NO

Capital Employed

-£45,246,000

-20.4%

-£37,577,000

-33.2%

-£28,216,000

-76.4%

-£16,000,000

-41.6%

-£11,300,000

Ratios

 

Date Of Accounts

31/03/13

31/03/12

31/03/11

31/03/10

31/03/09

Pre-tax profit margin %

-67.07

-120.86

-86.08

-65.47

-302.17

Current ratio

0.66

0.71

0.77

0.83

0.85

Sales/Net Working Capital

-0.30

-0.29

-0.55

-0.74

-0.32

Gearing %

-2.70

-3.30

0

0

0

Equity in %

-40.70

-33.80

-26.50

-16.40

-13.60

Creditor Days

69.68

58.88

35.24

68.08

205.73

Debtor Days

2.69

22.07

41.19

44.51

79.13

Liquidity/Acid Test

0.65

0.71

0.76

0.83

0.84

Return On Capital Employed %

24.38

40.73

52.62

56.87

123

Return On Total Assets Employed %

-9.64

-13.30

-13.94

-9.34

-16.68

Current Debt Ratio

-3.43

-3.92

-4.77

-7.08

-8.37

Total Debt Ratio

-3.45

-3.95

-4.77

-7.08

-8.37

Stock Turnover Ratio %

-

-

-

-

-

Return on Net Assets Employed %

23.71

39.37

52.62

56.87

123

 

 

FOREIGN EXCHANGE RATES

 

N/a

 

 

ADDITIONAL INFORMATION

 

Current Company Secretary

Name

Peter Frederick Burrell

Date of Birth

-

Officers Title

Mr

Nationality

British

Present Appointments

2

Function

Company Secretary

Appointment Date

19/07/2000

 

 

Address

One Prospect West, Chippenham, Wiltshire, SN14 6FH

 

Number of Employees

177

12%

158

-1.9%

161

13.4%

142

14.5%

124

 

Auditors

DELOITTE LLP

 

Auditor Comments

The audit report contains no adverse comments

 

Bankers

BARCLAYS BANK PLC

 

Bank Branch Code

20-17-35

Status History

No Status History found

Event History

Date

Description

 

28/11/2013

New Accounts Filed

View Document

28/11/2013

New Accounts Filed

View Document

02/09/2013

Annual Returns

View Document

12/07/2013

Ms A.P. Hyland has left the board

View Document

12/07/2013

New Board Member Mr P. Oliver appointed

View Document

08/01/2013

Annual Returns

View Document

08/01/2013

Annual Returns

View Document

21/12/2012

New Accounts Filed

View Document

21/12/2012

New Accounts Filed

View Document

25/09/2012

New Board Member Dr T.M. Phillips appointed

View Document

09/01/2012

Annual Returns

View Document

24/11/2011

New Accounts Filed

View Document

24/11/2011

New Accounts Filed

View Document

08/01/2011

Annual Returns

View Document

04/01/2011

New Accounts Filed

View Document

Previous Company Names

Date

Previous Name

Companies House Documents

13/07/2004

COORDINATED DRUG DEVELOPMENT LIMITED

View Document

 

 

NOTES & COMMENTS

 

Commentary

No exact match CCJs are recorded against the company.

 

There has been no significant change in the company's credit rating.

 

Sales in the latest trading period increased 29.9% on the previous trading period.

 

Net Worth decreased by 19.6% during the latest trading period.

 

A 0.6% decline in Total Assets occurred during the latest trading period.

 

 

Pre-tax profits increased by 27.9% compared to the previous trading period.

 

The company saw a decrease in their Cash Balance of 7.2% during the latest trading period.

 

The audit report contains no adverse comments.

 

The company has undergone recent changes in its directorships.

 

The company is part of a group.

 

The company was established over 30 years ago.

 

Show more

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.58.74

UK Pound

1

Rs.98.77

Euro

1

Rs.80.52

 

INFORMATION DETAILS

 

Analysis Done by :

KAR

 

 

Report Prepared by :

PDT

 

               

RATING EXPLANATIONS

 

RATING

STATUS

PROPOSED CREDIT LINE

 

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

 

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

 

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

 

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

 

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

 

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

 

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

Credit not recommended

 

--

NB

New Business

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.